Do not discontinue the medication without medical guidance, as abrupt cessation could adversely affect your diabetes control or weight management goals
There are also a few cautions the FDA notes specific to this drug, including but not limited to: risk of pancreatitis hypoglycemia (low blood sugar) when used in conjunction with certain other drugs renal impairment or kidney failure acute gallbladder disease increased risk of thyroid C-cell tumors The FDA notes that patients who have had, or have family members who have had, medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use liraglutide, nor should individuals who have experienced prior serious hypersensitivity reaction to the drug
In fact, the results from tirzepatide weight loss treatment often outperform those of single-agent medications like Ozempic, making it a preferred choice for comprehensive weight reduction
When taken on an empty stomach, it activates receptors in the small intestine and stimulates hormones like CCK, PYY, GLP-1, and leptin
(3) If you have been diagnosed or previously treated for any gallbladder disease, do not use semaglutide without first talking to a healthcare provider